3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Leukemia, Promyelocytic, Acute
4
Leukemia
3
Neuroblastoma
2
Multiple Myeloma
2
Leukemia, Myeloid, Acute
2
Wilms Tumor
1
Testicular Neoplasms
1
Teratoma
1
Skin Neoplasms
1
Sarcoma
1
Retinoblastoma
1
Recurrence
1
Ovarian Neoplasms
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Kidney Neoplasms
1
Hepatoblastoma
1
Endometrial Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Childhood Acute Promyelocytic Leukemia With PML-RARA
1
Central Nervous System Neoplasms
1
Carcinoma, Small Cell
1
Interventions
HhAntag691
14
sonidegib
4
methyl 5-aminolevulinate
3
Photochemotherapy
3
Aminolevulinic Acid
3
tazarotene
2
cemiplimab
2
IPI-926
2
Drug Evaluation
2
1-phenyl-3,3-dimethyltriazene
2
silmitasertib
1
remetinostat
1
prednylidene
1
pembrolizumab
1
deltacortene
1
Tacrolimus
1
Risk Factors
1
Prednisone
1
Nivolumab
1
NVP-BKM120
1
Mohs Surgery
1
Mindfulness
1
Midazolam
1
Itraconazole
1
Ipilimumab
1
IFL protocol
1
Folfox protocol
1
Fluorouracil
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Basal Cell
×
Arsenic Trioxide
×
Clear all
NCT01791894
2018-06-08
ATO
Stanford University
Phase 1/2
Completed
5 enrolled
9 charts